Altamira Therapeutics CYTOF Growth Metrics (2013-2025)

OTC CYTOF
$0.07 +0.00 (+0.00%)
At close: Nov 13, 2026 · 4:00 PM EST
Reported Financials

Altamira Therapeutics Quarterly Growth Metrics

Periods 36 quarters
Latest Jun 2025

Altamira Therapeutics reported asset growth of -28.33% for the quarter ended Jun 2025. These growth metrics cover 36 quarters of results from Sep 2013 through Jun 2025, standardized by Business Quant from the company’s SEC filings.

Growth MetricsGrowth Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Jun2019 Dec2019 Jun2020 Dec2020 Jun2021 Dec2021 Jun2022 Dec2022 Jan2023 Jun2023 Dec2023 Jun2024 Dec2024 Jun2025
Growth Ratios
Total Debt (QoQ)
-33.97%96.32%-55.37%
Total Debt Growth (5y)
-47.08%-38.71%-60.43%-9.19%-8.52%-9.32%-40.12%53.32%
Total Debt Growth (3y)
29.93%-40.34%-81.25%-61.42%-55.91%301.56%-42.61%-0.72%-55.12%
Total Debt Growth (1y)
-52.10%-19.69%-48.40%-85.90%-78.96%5,200.98%4,974.32%-30.92%-98.31%-96.38%8.91%261.02%
Share-based Compensation (QoQ)Stock Comp. (QoQ)
4.85%-10.69%-383.14%159.29%30.50%-25.68%
Share-based Compensation Growth (5y)Stock Comp. Growth (5y)
48.92%
Share-based Compensation Growth (3y)Stock Comp. Growth (3y)
-11.62%41.95%36.98%14.24%
Share-based Compensation Growth (1y)Stock Comp. Growth (1y)
-2.39%-8.73%-609.42%57.21%95.66%62.80%
Revenue (QoQ)
5.95%-7.10%-8.43%42.76%
Revenue Growth (3y)
304.09%193.54%311.33%360.89%
Revenue Growth (1y)
7.90%-0.33%-5.93%28.67%
Return on Sales [ROS] (QoQ)ROS (QoQ)
0.01M0.00M0.01M0.06M
Return on Sales [ROS] Growth (3y)ROS Growth (3y)
37.42M
Return on Sales [ROS] Growth (1y)ROS Growth (1y)
0.06M0.02M0.07M0.09M
Return on Invested Capital [ROIC] (QoQ)ROIC (QoQ)
0.01M-81.00-0.03M
Return on Invested Capital [ROIC] Growth (1y)ROIC Growth (1y)
0.01M-0.03M
Return on Equity [ROE] (QoQ)ROE (QoQ)
0.03M-204.00
Return on Equity [ROE] Growth (3y)ROE Growth (3y)
440.000.00M-0.08M
Return on Equity [ROE] Growth (1y)ROE Growth (1y)
0.01M0.01M-0.07M
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ)
0.01M-640.00-0.03M-0.04M-0.09M0.14M
Return on Capital Employed [ROCE] Growth (3y)ROCE Growth (3y)
0.00M-373.00-0.03M-0.07M-0.16M-0.02M
Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y)
0.01M0.01M-0.02M-0.06M-0.16M-0.02M
Return on Assets [ROA] (QoQ)ROA (QoQ)
0.00M-195.00-0.01M0.00M0.00M0.00M
Return on Assets [ROA] Growth (3y)ROA Growth (3y)
0.00M-619.00-0.01M-0.01M-0.01M-0.01M
Return on Assets [ROA] Growth (1y)ROA Growth (1y)
0.00M0.00M0.00M-0.01M-0.01M-0.01M
Property, Plant & Equipment (Net) (QoQ)PP&E (Net) (QoQ)
-11.62%-8.23%-7.12%-13.72%-77.78%-25.10%
Property, Plant & Equipment (Net) Growth (5y)PP&E (Net) Growth (5y)
-31.03%-40.90%-21.98%-26.32%-28.69%-33.30%-92.13%-91.99%-91.60%-91.73%-91.17%-87.20%-86.25%7.76%12.47%
Property, Plant & Equipment (Net) Growth (3y)PP&E (Net) Growth (3y)
2.95%2.76%2.75%-7.73%-43.46%-50.66%-52.47%-42.55%-43.57%-41.06%-50.59%-96.83%-96.28%-97.49%-97.56%-97.31%-97.18%-96.58%4,404.03%4,515.09%
Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y)
67.96%-28.83%-28.61%-35.00%-83.66%-86.66%-90.19%99.74%181.59%-23.14%-56.36%-100.00%-100.00%-0.99%-8.63%6.12%9.43%-10.09%8,433,500.41%10,301,600.00%
Operating Margin (QoQ)
0.01M0.00M0.01M0.06M
Operating Margin Growth (3y)
Operating Margin Growth (1y)
0.06M0.02M0.07M0.09M
Operating Income (QoQ)Op. Inc (QoQ)
4.50%4.57%17.67%30.31%7.86%76.91%
Operating Income Growth (5y)Op. Inc Growth (5y)
9.36%8.45%28.61%
Operating Income Growth (3y)Op. Inc Growth (3y)
2.47%1.77%15.49%32.59%26.98%53.85%
Operating Income Growth (1y)Op. Inc Growth (1y)
25.29%12.72%38.48%47.70%49.54%87.79%
Net Margin (QoQ)
-0.01M0.02M0.08M0.00M
Net Margin Growth (3y)
Net Margin Growth (1y)
0.06M0.02M0.17M0.09M
Net Income towards Common Stockholders (QoQ)Net Income (QoQ)
-14.09%22.66%67.89%-53.51%-19.77%-32.53%
Net Income towards Common Stockholders Growth (5y)Net Income Growth (5y)
14.34%9.81%1.54%
Net Income towards Common Stockholders Growth (3y)Net Income Growth (3y)
-19.14%1.47%43.94%41.28%19.83%11.59%
Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y)
23.63%12.36%81.18%56.51%54.35%21.76%
Net Income (QoQ)
-13.77%25.62%60.40%-69.99%3.17%-22.43%
Net Income Growth (5y)
9.46%8.62%0.87%
Net Income Growth (3y)
-19.29%-4.08%39.85%35.44%17.57%12.53%
Net Income Growth (1y)
22.76%14.55%78.00%43.04%51.52%20.21%
Net Cash Flow (QoQ)NCF (QoQ)
4.72%14.17%61.11%-300.23%111.54%287.39%
Net Cash Flow Growth (5y)NCF Growth (5y)
-19.46%17.35%-18.16%
Net Cash Flow Growth (3y)NCF Growth (3y)
-26.89%6.87%-33.09%-146.07%28.53%37.20%
Net Cash Flow Growth (1y)NCF Growth (1y)
-191.02%18.74%-208.59%-27.29%115.42%169.60%
Interest Coverage Ratio (QoQ)Interest Cover (QoQ)
8.28%-4.08%11.09%50.24%-279.70%68.41%
Interest Coverage Ratio Growth (5y)Interest Cover Growth (5y)
73.69%
Interest Coverage Ratio Growth (3y)Interest Cover Growth (3y)
-42.92%82.96%84.73%89.20%81.37%87.05%
Interest Coverage Ratio Growth (1y)Interest Cover Growth (1y)
28.52%7.99%29.82%57.77%-74.84%46.94%
Income After Tax (QoQ)
-13.74%26.62%59.97%-70.96%3.16%-19.99%
Income After Tax Growth (5y)
9.36%8.52%-2.72%
Income After Tax Growth (3y)
-19.40%-3.71%39.85%35.32%17.41%12.95%
Income After Tax Growth (1y)
22.55%15.47%78.00%42.89%51.37%20.49%
Free Cash Flow (QoQ)FCF (QoQ)
22.48%-32.06%19.64%55.43%-74.47%52.55%
Free Cash Flow Growth (5y)FCF Growth (5y)
12.12%1.28%16.33%
Free Cash Flow Growth (3y)FCF Growth (3y)
-17.84%-8.42%7.58%35.49%19.85%33.98%
Free Cash Flow Growth (1y)FCF Growth (1y)
28.95%-1.00%21.30%63.34%17.48%70.35%
FCF Margin (QoQ)
0.04M-0.05M0.02M0.10M
FCF Margin Growth (3y)
FCF Margin Growth (1y)
0.06M0.00M0.03M0.11M
EBT (QoQ)
-13.75%25.83%60.15%-69.63%3.16%-15.84%
EBT Margin (QoQ)
-0.01M0.03M0.07M-0.01M
EBT Margin Growth (3y)
EBT Margin Growth (1y)
0.06M0.02M0.17M0.08M
EBT Growth (5y)
9.41%8.57%0.09%
EBT Growth (3y)
-19.34%-4.03%39.75%35.38%17.49%14.04%
EBT Growth (1y)
22.66%16.69%77.91%42.96%51.44%24.17%
EBIT (QoQ)
4.50%4.57%17.67%30.31%7.86%76.91%
EBIT Margin (QoQ)
0.01M0.00M0.01M0.06M
EBIT Margin Growth (3y)
EBIT Margin Growth (1y)
0.06M0.02M0.07M0.09M
EBIT Growth (5y)
9.36%8.45%28.61%
EBIT Growth (3y)
2.47%1.77%15.49%32.59%26.98%53.85%
EBIT Growth (1y)
25.29%12.72%38.48%47.70%49.54%87.79%
EBITDA Margin (QoQ)
0.01M0.00M0.01M0.06M
EBITDA Margin Growth (3y)
EBITDA Margin Growth (1y)
0.06M0.02M0.07M0.09M
Cash from Operations (QoQ)Cash from Ops. (QoQ)
22.48%-32.06%19.64%55.43%-74.47%52.55%
Cash from Operations Growth (5y)Cash from Ops. Growth (5y)
12.12%1.28%16.33%
Cash from Operations Growth (3y)Cash from Ops. Growth (3y)
-17.65%-8.35%7.58%35.49%19.94%33.45%
Cash from Operations Growth (1y)Cash from Ops. Growth (1y)
28.95%-5.16%22.17%63.34%17.48%70.35%
Cash from Investing Activities (QoQ)Cash from Investing (QoQ)
-560.77%90.12%440.15%-2,820.89%
Cash from Investing Activities Growth (5y)Cash from Investing Growth (5y)
-11.45%37.36%-214.90%
Cash from Investing Activities Growth (3y)Cash from Investing Growth (3y)
-99.42%82.28%26.49%89.71%-417.93%
Cash from Investing Activities Growth (1y)Cash from Investing Growth (1y)
-454.84%96.91%-242.99%205.56%-28,971.31%
Cash & Equivalents (QoQ)Cash & Equiv. (QoQ)
-28.67%-21.91%-13.49%-66.51%21.42%1.88%
Cash & Equivalents Growth (5y)Cash & Equiv. Growth (5y)
-27.25%-15.31%-52.25%-77.05%-24.14%-22.77%-49.22%-57.29%-74.44%-74.46%-58.41%-33.15%-59.40%-6.92%-38.30%
Cash & Equivalents Growth (3y)Cash & Equiv. Growth (3y)
-32.98%-35.72%-36.35%-59.33%-54.48%-52.40%-43.84%-64.48%-88.48%-5.84%27.53%-41.87%-59.62%-77.32%-77.34%9.50%-61.44%-80.76%-2.49%-78.74%
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y)
-49.56%-52.04%-60.88%-83.86%-72.53%-64.16%33.80%-73.93%-99.29%793.37%21,793.90%-91.57%-95.75%-98.45%-98.46%-85.88%4,288.45%18.73%36.41%-94.26%
Capital Expenditures (QoQ)Capex (QoQ)
Capital Expenditures Growth (3y)Capex Growth (3y)
Capital Expenditures Growth (1y)Capex Growth (1y)
Assets (QoQ)
269.49%-83.80%-9.31%-54.68%10.09%21.85%
Assets Growth (5y)
-18.19%-6.86%-30.34%-34.29%-24.45%-6.80%-9.76%-8.64%-17.81%-17.85%-1.62%-1.90%-7.65%-1.90%-3.16%
Assets Growth (3y)
18.24%-32.05%-32.54%-52.16%-48.33%-52.86%-31.05%-35.23%-34.96%9.01%51.00%27.84%17.25%-10.50%-10.57%-6.25%-27.15%-32.10%-25.57%-28.33%
Assets Growth (1y)
164.94%-48.05%-55.42%-75.40%-92.67%-44.87%60.49%-5.14%-30.30%147.70%207.80%-11.07%-24.86%-67.45%-67.53%-64.37%33.58%16.95%-5.16%-11.64%

Altamira Therapeutics Growth Metrics API

Pull Altamira Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CYTOF&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY